Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle

Penio T. Todorov, Stacey M. Wyke, Michael J. Tisdale*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Proteolysis-inducing factor (PIF) is a sulfated glycoprotein produced by cachexia-inducing tumors, which induces atrophy of skeletal muscle. PIF has been shown to bind specifically with high affinity (Kd, in nanomolar) to sarcolemma membranes from skeletal muscle of both the mouse and the pig, as well as murine myoblasts and a human muscle cell line. Ligand binding was abolished after enzymatic deglycosylation, suggesting that binding was mediated through the oligosaccharide chains in PIF. Chondroitin sulfate, but not heparan or dermatan sulfate, showed competitive inhibition (Kd, 1.1 × 10-7 mol/L) of binding of PIF to the receptor, suggesting an interaction with the sulfated oligosaccharide chains. Ligand blotting of [ 35S]PIF to triton solublized membranes from C2C 12 cells provided evidence for a binding protein of apparent M r of ∼40,000. Amino acid sequence analysis showed the PIF receptor to be a DING protein. Antisera reactive to a 19mer from the N-terminal amino acid residues of the binding protein attenuated protein degradation and activation of the ubiquitin-proteasome pathway induced by PIF in murine myotubes. In addition, the antisera was highly effective in attenuating the decrease in body weight in mice bearing the MAC16 tumor, with a significant increase in muscle wet weight due to an increase in the rate of protein synthesis, together with a reduction in protein degradation through attenuation of the increased proteasome expression and activity. These results confirm that the PIF binding protein has a functional role in muscle protein atrophy in cachexia and that it represents a potential new therapeutic target. ©2007 American Association for Cancer Research.

Original languageEnglish
Pages (from-to)11419-11427
Number of pages9
JournalCancer Research
Volume67
Issue number23
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Proteolysis
Skeletal Muscle
Membranes
Carrier Proteins
Cachexia
Proteasome Endopeptidase Complex
Oligosaccharides
Immune Sera
Ligands
Dermatan Sulfate
Sarcolemma
Heparitin Sulfate
Muscular Atrophy
Muscle Proteins
Chondroitin Sulfates
Myoblasts
Skeletal Muscle Fibers
Protein Sequence Analysis
Ubiquitin
Muscle Cells

Keywords

  • cancer cachexia
  • proteolysis-inducing factor
  • receptorskeletal muscle
  • proteasome

Cite this

Todorov, Penio T. ; Wyke, Stacey M. ; Tisdale, Michael J. / Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle. In: Cancer Research. 2007 ; Vol. 67, No. 23. pp. 11419-11427.
@article{0cb79da944a340aab145a3390e8dd96a,
title = "Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle",
abstract = "Proteolysis-inducing factor (PIF) is a sulfated glycoprotein produced by cachexia-inducing tumors, which induces atrophy of skeletal muscle. PIF has been shown to bind specifically with high affinity (Kd, in nanomolar) to sarcolemma membranes from skeletal muscle of both the mouse and the pig, as well as murine myoblasts and a human muscle cell line. Ligand binding was abolished after enzymatic deglycosylation, suggesting that binding was mediated through the oligosaccharide chains in PIF. Chondroitin sulfate, but not heparan or dermatan sulfate, showed competitive inhibition (Kd, 1.1 × 10-7 mol/L) of binding of PIF to the receptor, suggesting an interaction with the sulfated oligosaccharide chains. Ligand blotting of [ 35S]PIF to triton solublized membranes from C2C 12 cells provided evidence for a binding protein of apparent M r of ∼40,000. Amino acid sequence analysis showed the PIF receptor to be a DING protein. Antisera reactive to a 19mer from the N-terminal amino acid residues of the binding protein attenuated protein degradation and activation of the ubiquitin-proteasome pathway induced by PIF in murine myotubes. In addition, the antisera was highly effective in attenuating the decrease in body weight in mice bearing the MAC16 tumor, with a significant increase in muscle wet weight due to an increase in the rate of protein synthesis, together with a reduction in protein degradation through attenuation of the increased proteasome expression and activity. These results confirm that the PIF binding protein has a functional role in muscle protein atrophy in cachexia and that it represents a potential new therapeutic target. {\circledC}2007 American Association for Cancer Research.",
keywords = "cancer cachexia, proteolysis-inducing factor, receptorskeletal muscle, proteasome",
author = "Todorov, {Penio T.} and Wyke, {Stacey M.} and Tisdale, {Michael J.}",
year = "2007",
month = "12",
doi = "10.1158/0008-5472.CAN-07-2602",
language = "English",
volume = "67",
pages = "11419--11427",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle. / Todorov, Penio T.; Wyke, Stacey M.; Tisdale, Michael J.

In: Cancer Research, Vol. 67, No. 23, 12.2007, p. 11419-11427.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle

AU - Todorov, Penio T.

AU - Wyke, Stacey M.

AU - Tisdale, Michael J.

PY - 2007/12

Y1 - 2007/12

N2 - Proteolysis-inducing factor (PIF) is a sulfated glycoprotein produced by cachexia-inducing tumors, which induces atrophy of skeletal muscle. PIF has been shown to bind specifically with high affinity (Kd, in nanomolar) to sarcolemma membranes from skeletal muscle of both the mouse and the pig, as well as murine myoblasts and a human muscle cell line. Ligand binding was abolished after enzymatic deglycosylation, suggesting that binding was mediated through the oligosaccharide chains in PIF. Chondroitin sulfate, but not heparan or dermatan sulfate, showed competitive inhibition (Kd, 1.1 × 10-7 mol/L) of binding of PIF to the receptor, suggesting an interaction with the sulfated oligosaccharide chains. Ligand blotting of [ 35S]PIF to triton solublized membranes from C2C 12 cells provided evidence for a binding protein of apparent M r of ∼40,000. Amino acid sequence analysis showed the PIF receptor to be a DING protein. Antisera reactive to a 19mer from the N-terminal amino acid residues of the binding protein attenuated protein degradation and activation of the ubiquitin-proteasome pathway induced by PIF in murine myotubes. In addition, the antisera was highly effective in attenuating the decrease in body weight in mice bearing the MAC16 tumor, with a significant increase in muscle wet weight due to an increase in the rate of protein synthesis, together with a reduction in protein degradation through attenuation of the increased proteasome expression and activity. These results confirm that the PIF binding protein has a functional role in muscle protein atrophy in cachexia and that it represents a potential new therapeutic target. ©2007 American Association for Cancer Research.

AB - Proteolysis-inducing factor (PIF) is a sulfated glycoprotein produced by cachexia-inducing tumors, which induces atrophy of skeletal muscle. PIF has been shown to bind specifically with high affinity (Kd, in nanomolar) to sarcolemma membranes from skeletal muscle of both the mouse and the pig, as well as murine myoblasts and a human muscle cell line. Ligand binding was abolished after enzymatic deglycosylation, suggesting that binding was mediated through the oligosaccharide chains in PIF. Chondroitin sulfate, but not heparan or dermatan sulfate, showed competitive inhibition (Kd, 1.1 × 10-7 mol/L) of binding of PIF to the receptor, suggesting an interaction with the sulfated oligosaccharide chains. Ligand blotting of [ 35S]PIF to triton solublized membranes from C2C 12 cells provided evidence for a binding protein of apparent M r of ∼40,000. Amino acid sequence analysis showed the PIF receptor to be a DING protein. Antisera reactive to a 19mer from the N-terminal amino acid residues of the binding protein attenuated protein degradation and activation of the ubiquitin-proteasome pathway induced by PIF in murine myotubes. In addition, the antisera was highly effective in attenuating the decrease in body weight in mice bearing the MAC16 tumor, with a significant increase in muscle wet weight due to an increase in the rate of protein synthesis, together with a reduction in protein degradation through attenuation of the increased proteasome expression and activity. These results confirm that the PIF binding protein has a functional role in muscle protein atrophy in cachexia and that it represents a potential new therapeutic target. ©2007 American Association for Cancer Research.

KW - cancer cachexia

KW - proteolysis-inducing factor

KW - receptorskeletal muscle

KW - proteasome

UR - http://www.scopus.com/inward/record.url?scp=37049031694&partnerID=8YFLogxK

UR - http://cancerres.aacrjournals.org/content/67/23/11419.full

U2 - 10.1158/0008-5472.CAN-07-2602

DO - 10.1158/0008-5472.CAN-07-2602

M3 - Article

C2 - 18056470

VL - 67

SP - 11419

EP - 11427

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 23

ER -